| Lab Tests | N/A |
| Treatment of Concomitant Diseases | No |
| Date of diagnosis | 2024/8/23 |
| Drinking History | Non-drinker |
| MMSE | 12 |
| Race | Caucasian |
| Donor ID | 36371 |
| Height, cm | 162 |
| Treatment | Medications: Memantine 10 mg, per os, once a day, since 23-Aug-2024 |
| Date of Draw | 2024/8/28 |
| Processing | Double spin |
| Weight, kg | 55 |
| Concomitant Diseases | No |
| Comments Data | Clinical symptoms: impairment of memory;
Date of MRI: 4-Jun-2024;
MRI Conclusion: MRI evidence of isolated focal changes in the white matter of the cerebral hemispheres of vascular origin (Fazekas I). Atrophic changes in the cerebral cortex and hippocampus (MTA 2). |
| Note | |
| Storage Condition | -70℃ |
| COVID-19 Vaccination | |
| HIV, HBV, HCV, RPR | Negative |
| Location Country | Ukraine |
| Smoking History | Non-smoker |
| Cancer History and Relapses | |
